5-HT transporter

Pharmacochemistry Library

Volumn 27, Issue C, 1997, Pages 327-361

  Soudijn, W ^a   van Wijngaarden, I ^b  

^a LEIDEN UNIVERSITY   (Netherlands)

^b Solvay Pharmaceuticals Inc   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77957082564     PISSN: 01657208     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0165-7208(97)80019-0     Document Type: Article

References (117)

1. Hoffman B.J., Mezey E., and Brownstein M.J. Science 254 (1991) 579-580
2. Blakely R.D., Berson H.E., Fremeau R.T., et al. Nature 354 (1991) 66-70
3. Lesch K.P., Wolozin B.L., Estler H.C., Murphy D.L., and Riederer P. J Neural Transm [Gen Sect] 91 (1993) 67-72
4. Mayser W., Betz H., and Schloss P. FEBS Lett 295 (1991) 203-206
5. Kyte J., and Doolittle R.F. J Mol Biol 157 (1982) 105-132
6. Von Heijne. Eur J Biochem 133 (1983) 17-21
7. Kemp B.E., and Pearson R.B. TIBS 15 (1990) 342-346
8. Anderson G.M., and Horne W.C. Biochim Biophys Acta 1137 (1992) 331-337
9. Anderson G.M., and Horne W.C. Biochim Biophys Acta 1137 (1992) 331-337
10. Myers C.L., Lazo J.S., and Pitt B.R. Am J Physiol 257 (1989) L253-L258
11. Cool D.R., Leibach F.H., and Bhalla V.K. J Biol Chem 266 (1991) 15750-15757
12. Ramamoorthy S., Cool D.R., Mahesh V.B., et al. J Biol Chem (1993) 21626-21631
13. Rudnick G. J Biol Chem 252 (1977) 2170-2174
14. Nelson P.J., and Rudnick G. J Biol Chem 254 (1979) 10084-10089
15. Rudnick G., and Nelson P.J. Biochemistry 17 (1978) 4739-4742
16. Nelson P.J., and Rudnick G. J Biol Chem 257 (1982) 6151-6155
17. Keyes S.R., and Rudnick G. J Biol Chem 257 (1982) 1172-1176
18. Talvenheimo J., Fishkes H., Nelson P.J., and Rudnick G. J Biol Chem 258 (1983) 6115-6119
19. O'Reilly C.A., and Reith M. J Biol Chem 263 (1988) 6115-6121
20. Reith M., Zimanyi I., and O'Reilly C.A. Biochem Pharmacol 38 (1989) 2091-2097
21. Wood M.D. Neuropharmacology 26 (1987) 1081-1085
22. Mann C.D., and Hrdina P.D. J Neurochem 59 (1992) 1856-1861
23. Humphreys C.J., Levin J., and Rudnick G. Mol Pharmacol 33 (1988) 657-663
24. Graham D., Esnaud H., Habert E., and Langer S.Z. Biochem Pharmacol 38 (1989) 3819-3826
25. Plenge P., Mellerup E.T., and Laursen H. Eur J Pharmacol Mol Pharmacol Sect 206 (1991) 243-250
26. Plenge P., and Mellerup E.T. J Neurochem 56 (1991) 248-252
27. Richelson E., and Pfenning M. Eur J Pharmacol 104 (1984) 277-286
28. Richardson E., and Nelson A. J Pharmacol Exp Therap 230 (1984) 94-102
29. Heal D., Cheetham S., Martin K., et al. Drug Dev Res 27 (1992) 121-135
30. Luscombe G.P., and Buckett W.R. Drug Dev Res 29 (1993) 235-248
31. Maj J., Statal, Górka Z., and Adamus A. Psychopharmacology 78 (1982) 165-169
32. Pawlowski L., Nowak G., Görka Z., and Mazela H. Psychopharmacology 86 (1985) 156-163
33. Hyttel J. Prog Neuro Psychopharmacol Biol Psychiat 6 (1982) 277-295
34. Hyttel J., and Larssen J.J. Acta Pharmacol Toxicol 56 suppl 1 (1985) 146-153
35. Sindelár K., Holubek J., Matousová O., et al. Coll Czech Chem Commun 53 (1988) 340-360
36. Pinder R.M., and Wieringa J.H. Med Research Reviews 13 (1993) 259-325
37. Bradford L.D., Tulp M., and Schipper J. Arch Int Pharmacodyn 287 (1987) 188-202
38. Claassen V., Davies J.E., Hertting G., and Placheta P. Brit J Pharmacol 60 (1977) 505-516
39. Claassen V. Brit J Clin Pharmacol 15 Suppl 3 (1983) 357S-364S
40. Benfield P., and Ward A. Drugs 32 (1986) 313-334
41. Wilde M.I., Plosker G.L., and Benfield P. Drugs 46 (1993) 895-924
42. Ross S.B., and Renyi A.L. Neuropharmacology 16 (1977) 57-63
43. Högberg T., Ulff B., Renyi A.L., and Ross S.B. J Med Chem 24 (1981) 1499-1507
44. Marcusson J.O., Norinder U., Högberg T., and Ross S.B. Eur J Pharmacol 215 (1992) 191-198
45. Högberg T., Ross S.B., Ström P., et al. J Med Chem 31 (1988) 913-919
46. Muth E.A., Haskins J.T., Moyer J.A., et al. Biochem Pharmacol 35 (1986) 4493-4497
47. Yardley J.P., Husbands G., Stack G., et al. J Med Chem 33 (1990) 2899-2905
48. Muth E.A., Moyer J.A., Haskins T., et al. Drug Develop Research 23 (1991) 191-199
49. Fuller R.W., Wong D.T., and Robertson D.W. Med Research Revs 11 (1991) 17-34
50. Wong D.T., Bymaster F.P., Reid L.R., and Threlkeld P.G. Biochem Pharmacol 32 (1983) 1287-1293
51. Wong D.T., Threlkeld P.G., and Robertson D.W. Neuropsychopharmacol 5 (1991) 43-47
52. Robertson D.W., Krushinski J.H., Fuller R.W., and Leander J.D. J Med Chem 31 (1988) 1412-1417
53. Wong D.T., Bymaster F.P., Reid L.R., et al. Drug Develop Research 6 (1985) 397-403
54. Wong D.T., Bymaster F.P., Reid L.R., et al. Neuropsychopharmacol 8 (1993) 337-344
55. Wong D.T., Horng J.S., and Bymaster F.P. Life Sci 17 (1975) 755-760
56. Wong D.T., Threlkeld P.G., Best K.L., and Bymaster F.P. J Pharmacol Exp Therap 222 (1982) 61-65
57. Gehlert DR et al. Euro Patent EP 534756, EP 537915.
58. Chumpradit S., Kung M.P., Panyachotipun C., et al. J Med Chem 35 (1992) 4492-4497
59. Kung M.P., Chumpradit S., Billings J., and Kung H. Life Sci 51 (1992) 95-106
60. Cregge R., Wagner E.R., Freedman J., and Margolin A.L. J Org Chem 55 (1990) 4237-4238
61. Michals D.R., and Smith H.E. Chirality 5 (1993) 20-23
62. Bolden-Watson C., and Richelson E. Life Sciences 52 (1993) 1023-1029
63. Thomas D.R., Nelson D.R., and Johnson A.M. Psychopharmacol (1987) 193-200
64. Plenge P., Mellerup E.T., Honoré T., and Lefèvre Honoré P. J Pharm Pharmacol 39 (1987) 877-882
65. Mathis C., Gerdes J.M., Enas J.D., et al. J Pharm Pharmacol 44 (1992) 801-805
66. Habert E., Graham D., Tahraouil L., et al. Eur J Pharmacol 118 (1985) 107-114
67. Cheetham S.C., Viggers J.A., Slater N.A., et al. Neuropharmacology 32 (1993) 737-743
68. Marcusson J.O., Andersson A., and Bäckström I. Psychopharmacology 99 (1989) 17-21
69. Scatton B., Claustre Y., Graham D., et al. Drug Dev Res 12 (1988) 29-40
70. Angel I., Schoemaker H., Prouteau M., et al. Eur J Pharmacol 232 (1993) 139-145
71. Koe B.K., Weissman A., Welch W.M., and Browne R.G. J Pharmacol Exp Therap 226 (1983) 686-700
72. Murdock D., and McTravish D. Drugs 44 (1992) 604-624
73. Welch W.M., Kraska A.R., Sarges R., and Koe B.K. J Med Chem 27 (1984) 1508-1515
74. Guthrie S. DICP Annals Pharmacotherapy 25 (1991) 952-959
75. Bøgesø K.P., Christensen A.V., Hyttel J., and Liljefors T. J Med Chem 28 (1985) 1817-1828
76. Milne R.J., and Goa K.L. Drugs 41 (1991) 450-477
77. Maitre L., Baumann P.A., Jaekel J., et al. In: Ho B.T., et al. (Ed). Serotonin in Biological Psychiatry (1982), Raven, New York 229-246
78. Pawlowski L., and Nowak G. J Pharmacy Pharmacology 39 (1987) 1003-1009
79. Bigler J., Bøgesø K.P., Toft A., and Hansen W. Eur J Med Chem 12 (1977) 289-295
80. Maryanoff B.E., McComsey D.F., Gardocki J.F., et al. J Med Chem 30 (1987) 1433-1454
81. Maryanoff B.E., Vaught J.L., Shank R.P., et al. J Med Chem 33 (1990) 2793-2797
82. Suehiro M., Scheffel U., Ravert H.T., et al. Life Sciences 53 (1993) 883-892
83. Le Fur G., and Uzan A. Biochemical Pharmacology 26 (1977) 497-503
84. Le Fur G., Kabouche M., and Uzan A. Life Sciences 23 (1987) 1959-1966
85. Le Fur G., Mitrani N., and Uzan A. Biochemical Pharmacology 26 (1977) 505-509
86. Bénavidès J., Savaki H.E., Malgouris C., et al. J Neurochem 45 (1985) 514-520
87. Classen K., Göthert M., and Schlicker E. Arch Pharmacol 326 (1984) 198-202
88. Vaatstra W.J., Deimann-Van Aalst W., and Eigeman L. Eur J Pharmacol 70 (1981) 195-202
89. Hashimoto K., and Goromaru T. Neuropharmacology 31 (1990) 869-874
90. Mathis C., Biegon A., Taylor S.E., et al. Eur J Pharmacol 210 (1992) 103-104
91. Mathis C., Taylor S.E., Biegon A., and Enas J.D. Brain Res 619 (1993) 229-235
92. Biegon A., Mathis C., Hanrahan S.M., and Jagust W.J. Brain Res 619 (1993) 236-245
93. Jagust W.J., Eberling J.L., Roberts J.A., et al. Eur J Pharmacol 242 (1993) 189-193
94. Moore K.R., and Blakely R.D. Biotechniques 17 (1994) 130-136
95. Barker E.L., Kimmel H.L., and Blakely R.D. J Pharmacol Exp Therap 46 (1994) 799-807
96. Blakely R.D., Moore K.R., and Qian Y. Soc Gen Physiol Ser 48 (1993) 283-300
97. Miller K.J., and Hoffman B.J. J Biol Chem 269 (1994) 27351-27356
98. Wotherspoon G., Albert M., Rattray M., and Priestly J.V. Neurosci Lett 173 (1994) 31-36
99. Silverthorn M.L., Dersch C., Bauman M.H., et al. J Pharmacol Exp Therap 273 (1995) 213-222
100. Rothman R.B., Cadet J.L., Akunne H.C., et al. J Pharmacol Exp Therap 270 (1994) 296-309
101. Moyer J.A., Haskins J.T., Husbands G., and Muth E.A. Clin Neuropharmacol 15 Suppl. 1 Part B (1992) 435B
102. Mendlewicz J. International Clin Psychopharmacol 10 Suppl 2 (1995) 5-13
103. Holliday S.M., and Benfield P. Drugs 49 (1995) 280-294
104. Tanda G., Frau R., and DiChiara G. Psychopharmacology 119 (1995) 15-19
105. Carboni E., and DiChiara G. Neuroscience 32 (1989) 637-645
106. Tanda G., Carboni E., Frau R., and DiChiara G. Psychopharmacology 115 (1994) 285-288
107. Wong D.T., Bymaster F.P., Mayle D.A., et al. Neuropsychopharmacology 8 (1993) 23-33
108. Kihara T., and Ikeda M. J Pharmacol Exp Therap 272 (1995) 177-183
109. Katoh A., Eigyo M., Ishibashi C., et al. J Pharmacol Exp Therap 272 (1995) 1067-1075
110. Dubovsky S.L. J Clin Psychiatry 55 2 Suppl. (1994) 34-44
111. Kilts C.D. The American J of Medicine 97 Suppl 6A (1994) 3S-12S
112. Andrews J.M., and Nemeroff C. The American J of Medicine 97 Suppl 6A (1994) 24S-32S
113. Baldwin D., and Rudge S. International Clin Psychopharmacology 9 Suppl 4 (1995) 41-45
114. Dubovsky S.L., and Thomas M. J Clin Psychiatry 56 Suppl 2 (1995) 38-48
115. Leonard B.E. CNS Drugs 4 Suppl 1 (1995) 1-12
116. Schloss P., and Betz H. Biochemistry 34 (1995) 12590-12595
117. Barker E.L., and Blakely R.D. Mol Pharmacol 50 (1996) 957-965